Jeffrey S. Hatfield's Net Worth
$8.34 Million
Who is Jeffrey S. Hatfield?
Jeffrey S. Hatfield has an estimated net worth of $8.34 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., Vir Biotechnology, Inc., ZAFGEN, INC., INVIVO THERAPEUTICS HOLDINGS CORP., aTYR PHARMA INC, Vitae Pharmaceuticals, Inc, and AMBIT BIOSCIENCES CORP.
SEC CIK
Jeffrey S. Hatfield's CIK is 0001609879
Past Insider Trading and Trends
2015 was Jeffrey S. Hatfield's most active year for acquiring shares with 8 total transactions. Jeffrey S. Hatfield's most active month to acquire stocks was the month of April. 2016 was Jeffrey S. Hatfield's most active year for disposing of shares, totalling 12 transactions. Jeffrey S. Hatfield's most active month to dispose stocks was the month of September. 2015 saw Jeffrey S. Hatfield paying a total of $315,106.90 for 172,810 shares, this is the most they've acquired in one year. In 2016 Jeffrey S. Hatfield cashed out on 743,732 shares for a total of $12,100,058.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.61% | 8K |
—
|
—
| 23.81K |
May 30
| |||
Form 4
| +61.63% | 6.03K |
—
|
—
| 15.81K |
May 22
| |||
Form 4
| +189.83% | 6.41K |
—
|
—
| 9.78K |
May 23
| |||
Form 4
|
∞
| 3.37K |
—
|
—
| 3.37K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ZAFGEN, INC. (LRMR) Snapshot price: $8.05
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
aTYR PHARMA INC (LIFE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |